New Lucentis pricing to increase NHS prescriptions

pharmafile | August 29, 2008 | News story | Sales and Marketing |  Lucentis, ophth 

Related Content

novartis_window

Novartis’ Lucentis secures European approval for infants with rare eye disease

Novartis has made the surprise announcement that its VEGF inhibitor Lucentis (ranibizumab) has been awarded …

Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration

Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of …

Roche granted further good news by FDA

Roche was given further good news by FDA after receiving a Priority Review for its …

The Gateway to Local Adoption Series

Latest content